Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2015-04-15
Original SEC Filing: Click here

---

Webplus: SVA/20150415/6-K/2_EX-99.1/000.htm SEC Original: v407353_ex99-1.htm
Sinovac Provides Updates on Pipeline Vaccines BEIJING, March 17, 2015 /PRNewswire/ — Sinovac Biotech Ltd. ), a leading provider of biopharmaceutical products in China, today provided updates on the Company’s pipeline vaccines. EV71 vaccine. EV71 is a virus that causes hand, foot and mouth disease (HFMD) and is the primary cause of most severe and fatal cases of hand, foot

---

---

Webplus: SVA/20150415/6-K/3_EX-99.2/000.htm SEC Original: v407353_ex99-2.htm
Sinovac to Participate in China Medical and Healthcare Investment Conference Beijing, March 18,2014/PRNewswire/–Sinovac Biotech Ltd.(NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the Company will participate in the China Medical and Healthcare Investment Conference sponsored by T.H capital and Dong Xing Security, to be held at China World Hotel from March 23 to March 25. The

---

---

Webplus: SVA/20150415/6-K/4_EX-99.3/000.htm SEC Original: v407353_ex99-3.htm
Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2014 Unaudited Financial Results BEIJING, April 10, 2015 — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the fourth quarter and full year, ended December 31, 2014, before market opens on Monday,

---

---

Webplus: SVA/20150415/6-K/1/000.htm SEC Original: v407353_6k.htm

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2015-04-15CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085